Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies antibody response after booster vaccination more than 10 years after pre-exposure immunization
NL-OMON47356Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2016
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Rabies vaccine in rabies (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Fourfold increase in rabies antibody titer. Started Jun 2016; status: active, not recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NL-OMON47356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47356.